Related Experiment Videos

A point mutation at codon 13 of the N-ras oncogene in a human stomach cancer

Insights

Researchers discovered an activated N-ras oncogene in human stomach cancer. A specific mutation was identified, marking the first observation of this activated oncogene in gastric adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric adenocarcinoma is a significant global health concern.
  • Oncogene activation plays a crucial role in cancer development.
  • The N-ras oncogene's role in human stomach cancer is not well-established.

Purpose of the Study:

  • To investigate the presence and nature of N-ras oncogene activation in human stomach cancer.
  • To identify specific mutations within the N-ras gene in gastric adenocarcinoma samples.

Main Methods:

  • Surgical removal and histological diagnosis of human stomach cancer (poorly differentiated adenocarcinoma).
  • In vivo selection assay in nude mice using transfected NIH3T3 cells to detect oncogene activation.
  • Analysis of the N-ras gene using synthetic 20-mer oligonucleotide probes to identify point mutations.

Main Results:

  • Detection of an activated N-ras oncogene in the human stomach cancer sample.
  • Identification of a specific point mutation (G to C) at codon 13 of the N-ras gene.
  • This mutation results in the substitution of glycine with arginine.

Conclusions:

  • This study reports the first observation of an activated N-ras oncogene in human stomach cancer.
  • The identified mutation in codon 13 of N-ras may contribute to the development of gastric adenocarcinoma.
  • Further research is warranted to explore the implications of N-ras activation in stomach cancer.

Related Concept Videos